Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Editorial

Current Challenges in the Management of Neurological Disorders (Part-II)

Author(s): Mohammad Amjad Kamal and Mohamed M. Abdel-Daim

Volume 26 , Issue 37 , 2020

Page: [4687 - 4689] Pages: 3

DOI: 10.2174/138161282637200925103303

[1]
Uddin Md S, Kabir Md T, Rahman Md H, et al. Exploring the Multifunctional Neuroprotective Promise of Rasagiline Derivatives for Multi-Dysfunctional Alzheimer’s Disease. Curr Pharm Des 2020; 26(37): 4690-8.
[2]
Mueed Z, Mehta D, Rai PK, Kamal MA, Poddar NK. Cross-Interplay between Osmolytes and mTOR in Alzheimer’s Disease Pathogenesis. Curr Pharm Des 2020; 26(37): 4699-711.
[3]
Arslan J, Gilani AU, Jamshed H, Khan SF, Kamal MA. Edible Nuts for Memory. Curr Pharm Des 2020; 26(37): 4712-20.
[4]
Kumar B, Pandey M, Pottoo FH, Fayaz F, Sharma A, Sahoo PK. Liposomes: Novel Drug Delivery Approach for Targeting Parkinson’s Disease. Curr Pharm Des 2020; 26(37): 4721-37.
[5]
Ghanta MK, Elango P, Bhaskar LVKS. Current Therapeutic Strategies and Perspectives for Neuroprotection in Parkinson’s Disease. Curr Pharm Des 2020; 26(37): 4738-46.
[6]
Asif M, Usman M, Ayub S, et al. Role of ATP-Binding Cassette Transporter Proteins in CNS Tumors: Resistance-Based Perspectives and Clinical Updates. Curr Pharm Des 2020; 26(37): 4747-63.
[7]
Liu S, Wang L, Jiang D, et al. Sumoylation as an Emerging Target in Therapeutics against Cancer. Curr Pharm Des 2020; 26(37): 4764-76.
[8]
Mollazadeh H, Mohtashami E, Mousavi SH, et al. Deciphering the Role of Glutamate Signaling In Glioblastoma Multiforme: Current Therapeutic Modalities and Future Directions. Curr Pharm Des 2020; 26(37): 4777-88.
[9]
Chen P, Li Z, Li Y, Ahmad SS, Kamal MA, Huo X. The Language Development Via FOXP2 in Autism Spectrum Disorder: A Review. Curr Pharm Des 2020; 26(37): 4789-95.
[10]
Fathi M, Hussein AS, Elghazaly SM, et al. Effect of Botulinum Toxin on Equinus Foot Deformity in Cerebral Palsy Patients: A Systematic Review and Network Meta-analysis. Curr Pharm Des 2020; 26(37): 4796-807.
[11]
Liu S, Dang M, Lei Y, et al. Ajmalicine and its Analogues Against AChE and BuChE for the Management of Alzheimer’s Disease: An In-silico Study. Curr Pharm Des 2020; 26(37): 4808-14.

© 2022 Bentham Science Publishers | Privacy Policy